Princeton, NJ, United States of America

Bruce S Ross

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 543(Granted Patents)


Location History:

  • Carlsbad, CA (US) (1995 - 2006)
  • Princeton, NJ (US) (2013 - 2015)

Company Filing History:


Years Active: 1995-2015

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Bruce S. Ross: Innovator in Nucleoside Analog Research

Introduction

Bruce S. Ross is a prominent inventor based in Princeton, NJ (US). He has made significant contributions to the field of nucleoside analogs, holding a total of 13 patents. His work focuses on enhancing the properties of oligomeric compounds, which are crucial in various biotechnological applications.

Latest Patents

Among his latest patents, Bruce S. Ross has developed bicyclic cyclohexose nucleic acid analogs. This invention provides bicyclic cyclohexose nucleoside analogs and oligomeric compounds that incorporate these nucleoside analogs. These bicyclic nucleoside analogs are particularly useful for enhancing the nuclease resistance of oligomeric compounds. Additionally, he has worked on bicyclic cyclohexitol nucleic acid analogs, which are expected to similarly enhance the properties of oligomeric compounds, including nuclease resistance.

Career Highlights

Bruce S. Ross is associated with Isis Pharmaceuticals, Inc., where he continues to innovate in the field of nucleic acid research. His work has been instrumental in advancing the understanding and application of nucleoside analogs in therapeutic contexts.

Collaborations

He has collaborated with notable colleagues such as Phillip Dan Cook and Kelly G. Sprankle, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Bruce S. Ross stands out as a key figure in the development of nucleoside analogs, with a strong portfolio of patents that reflect his innovative spirit and dedication to advancing biotechnological research. His contributions continue to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…